Literature DB >> 6407330

Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D.

J K Spitznagel, K J Goodrum, D J Warejcka.   

Abstract

Heat-killed streptococci of Groups A, B, and D injected intraperitoneally into Sprague-Dawley rats induced arthritis. The histopathologic features of the arthritis were those of erosive synovitis. Early acute lesions were associated with deposits of streptococcal antigens. The serogroups and the physical state of the streptococci determined the incidence, the time of onset, the duration, and the severity of the disease, the severity being a blend of degree of inflammation, tendency to relapse, and occurrence of ankylosis. Whole Group A usually failed to induce arthritis. Group A disrupted with sonication regularly induced arthritis after a 24-hour latent period. The disease lasted over 60 days and caused ankylosis. Whole Group B regularly induced arthritis but only after a latent period of 6-8 days. The disease lasted over 40 days and caused ankylosed joints. With sonicated Group B a similar disease was induced, except that, as with sonicated Group A, the latent period was 24 hours. Whole Group D induced disease after a latent period of 48 hours. The arthritis lasted only 2 weeks and was transient. In contrast to its effects on Group A and B cocci, sonication of Group D abrogated its capacity to induce arthritis. It is postulated that for whole streptococci, in contrast to sonicated streptococci, arthritogenicity depends on the sensitivity of the cocci to initial processing in vivo. Processing may be partial digestion by enzymes of phagocytes. Cocci such as those of Group A that are insensitive to processing, injected whole, tend not to cause arthritis, but when they do cause disease, it is chronic. A coccus, such as one of Group D, that is very sensitive to processing produces a transient arthritis after a short latent period, while a coccus of intermediate sensitivity, such as one of Group B, induces disease only after a substantial latent period, and the disease is severe and chronic. The nature of processing remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407330      PMCID: PMC1916309     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

Review 2.  Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae.

Authors:  I Ginsburg
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

3.  Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes.

Authors:  A D Glick; J M Ranhand; R M Cole
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

Review 4.  Group B streptococci in human disease.

Authors:  M J Patterson; A El Batool Hafeez
Journal:  Bacteriol Rev       Date:  1976-09

5.  Relationship of complement to experimental arthritis induced in rats with streptococcal cell walls.

Authors:  J H Schwab; J B Allen; S K Anderle; F Dalldorf; R Eisenberg; W J Cromartie
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

6.  Degradation of streptococcal cell wall antigens in vivo.

Authors:  J H Schwab; S H Ohanian
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

7.  Lysis of grouped and ungrouped streptococci by lysozyme.

Authors:  S E Coleman; I van de Rijn; A S Bleiweis
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

8.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

9.  Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.

Authors:  Y H Chang; C M Pearson; L Chedid
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  15 in total

1.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

2.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysaccharide fragments.

Authors:  S A Stimpson; R A Lerch; D R Cleland; D P Yarnall; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 5.  Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans.

Authors:  J H Schwab
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

7.  Comparison of inflammatory reactions induced by intraarticular injection of bacterial cell wall polymers.

Authors:  R E Esser; S K Anderle; C Chetty; S A Stimpson; W J Cromartie; J H Schwab
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

8.  In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.

Authors:  M J Janusz; R E Esser; J H Schwab
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Comparison of in vivo degradation of 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci.

Authors:  S A Stimpson; R E Esser; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

10.  Arthropathic properties of cell wall polymers from normal flora bacteria.

Authors:  S A Stimpson; R R Brown; S K Anderle; D G Klapper; R L Clark; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.